Case number 1:21-cv-01710
Galderma Laboratories L.P. et al v. Lupin Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 2, 2024 | 202 | Notice of Appeal* (1) |
| Jun 8, 2023 | 121 | NOTICE OF SERVICE of Opening Expert Report of Edward M. Rudnic, Ph.D. Regarding Lupin's Infringement of U.S. Patent Nos. 7,749,532 and 8,206,740 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 06/08/2023) (3) |
| May 26, 2023 | 120 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendants' Fourth Set of Interrogatories (Nos. 17-21) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 05/26/2023) (3) |
| May 12, 2023 | 119 | NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents and (2) Plaintiffs' Third Supplemental Infringement Claim Chart filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 05/12/2023) (3) |
| May 11, 2023 | 117 | NOTICE OF SERVICE of Lupin's Supplemental Responses and Objections to Plaintiffs' Request for Production No. 134 and Lupin's Supplemental Responses and Objections to Plaintiffs' Interrogatories (Nos. 1-2) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 05/11/2023) (2) |
| May 11, 2023 | 118 | SO ORDERED, re 116 STIPULATION of Dismissal and [Proposed] Order of Claims and Defenses Relating to U.S. Patent Nos. 8,394,405, 8,394,406, 8,470,364, and 8,709,478. Ordered by Judge Stephanos Bibas on 05/11/2023. (smg) (Entered: 05/11/2023) (0) |
| May 10, 2023 | 116 | STIPULATION of Dismissal and [Proposed] Order of Claims and Defenses Relating to U.S. Patent Nos. 8,394,405, 8,394,406, 8,470,364, and 8,709,478 by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 05/10/2023) (4) |
| May 9, 2023 | 115 | NOTICE to Take Deposition of Liza Dahm on May 12, 2023 filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 05/09/2023) (2) |
| May 3, 2023 | 113 | SO ORDERED, re 112 STIPULATION TO EXTEND TIME for the parties (1) to serve opening expert reports; (2) to serve rebuttal expert reports; and (3) to serve reply expert reports to June 7, 2023; July 12, 2023; and August 16, 2023. Ordered by Judge Stephanos Bibas on 5/3/2023. (twk) (Entered: 05/03/2023) (0) |
| May 3, 2023 | 114 | ORAL ORDER, The scheduling order (D.I. 18 ) is modified as follows: The Court will hold a pretrial conference by Zoom at 10 a.m. eastern time on November 15, 2023. Trial will begin on January 9, 2024, in courtroom 4-B of the Byrne courthouse in Philadelphia. Ordered by Judge Stephanos Bibas on 5/3/2023. (twk) (Entered: 05/03/2023) (0) |
| May 2, 2023 | 112 | STIPULATION TO EXTEND TIME for the parties (1) to serve opening expert reports; (2) to serve rebuttal expert reports; and (3) to serve reply expert reports to June 7, 2023; July 12, 2023; and August 16, 2023 - filed by Lupin Inc., Lupin Limited. (Haney, Megan) (Entered: 05/02/2023) (2) |
| Apr 27, 2023 | 111 | NOTICE to Take Deposition of Sean Griffin on April 28, 2023 filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 04/27/2023) (2) |
| Apr 11, 2023 | 110 | Official Transcript of Telephone Conference held on 03/30/2023 before Judge Bibas. Court Reporter/Transcriber Brian Gaffigan,Email: gaffigan.b@outlook.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 5/2/2023. Redacted Transcript Deadline set for 5/12/2023. Release of Transcript Restriction set for 7/10/2023. (smg) (Entered: 04/11/2023) (0) |
| Apr 7, 2023 | 108 | MEMORANDUM OPINION. Signed by Judge Stephanos Bibas on 04/07/2023. (smg) (Entered: 04/10/2023) (10) |
| Apr 7, 2023 | 109 | ORDER Regarding Terms of US Patent Nos. 7,749,532; 8,206,740; 8,394,405; 8,394,406; 8,470,364; and 8,709,478. (See Order for additional details) Signed by Judge Stephanos Bibas on 04/07/2023. (smg) (Entered: 04/10/2023) (1) |
| Apr 6, 2023 | 107 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Fifth Set of Interrogatories (Nos. 22-25) and (2) Plaintiffs' Objections and Responses to Defendants' Fifth Set of Requests for Production (Nos. 20-33) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 04/06/2023) (3) |
| Apr 3, 2023 | 105 | NOTICE to Take Deposition of Rajiv Khurana on April 14, 2023 or a mutually agreeable date filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 04/03/2023) (3) |
| Apr 3, 2023 | 106 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs Second Set of Interrogatories (Nos. 8-11) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 04/03/2023) (2) |
| Mar 31, 2023 | 104 | NOTICE OF SERVICE of Plaintiffs' Corrected Objections and Responses to Defendants' Fourth Set of Interrogatories (Nos. 17-21) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/31/2023) (3) |
| Mar 30, 2023 | 102 | ORAL ORDER, Because defendant has failed to show good cause, I DENY its motion to amend (D.I. 86 ). Signed by Judge Stephanos Bibas on 03/30/2023. (apk) (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 103 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Fourth Set of Interrogatories (Nos. 17-21) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/30/2023) (3) |
| Mar 27, 2023 | 100 | NOTICE to Take Deposition of Pramod Dahibhate on April 5, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/27/2023) (3) |
| Mar 27, 2023 | 101 | REDACTED VERSION of 93 Letter, by Lupin Inc., Lupin Limited. (Phillips, John) (Entered: 03/27/2023) (4) |
| Mar 24, 2023 | 97 | [SEALED] Transcript of Markman Hearing held on 3/14/2023 before Judge Stephanos Bibas. (nmg) (Entered: 03/24/2023) (0) |
| Mar 24, 2023 | 98 | REDACTED VERSION of 92 Letter, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-8)(Tigan, Jeremy) (Entered: 03/24/2023) (Main Document) (5) |
| Mar 24, 2023 | 99 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Lupin Inc. and Lupin Limited's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/24/2023) (3) |
| Mar 24, 2023 | 98 | REDACTED VERSION of 92 Letter, by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-8)(Tigan, Jeremy) (Entered: 03/24/2023) (Exhibits 1-8) (30) |
| Mar 21, 2023 | 95 | NOTICE of Subpoena by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1)(Phillips, John) (Entered: 03/21/2023) (Main Document) (1) |
| Mar 21, 2023 | 96 | NOTICE to Take Deposition of Makarand Avachat on March 29, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/21/2023) (3) |
| Mar 21, 2023 | 95 | NOTICE of Subpoena by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1)(Phillips, John) (Entered: 03/21/2023) (Exhibit 1) (4) |
| Mar 20, 2023 | 93 | [SEALED] Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Reply in Support of Defendants' Motion for Leave to Amend Answer and Counterclaims - re 86 MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims. (Phillips, John) (Entered: 03/20/2023) (0) |
| Mar 20, 2023 | 94 | Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding request for a teleconference on Lupin's Motion for Leave to Amend Answer and Counterclaims (D.I. 86). (Phillips, John) (Entered: 03/20/2023) (1) |
| Mar 17, 2023 | 92 | [SEALED] Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Plaintiffs' Opposition to Lupin's Motion for Leave to Amend Answer and Counterclaims - re 86 MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims. (Attachments: # 1 Exhibits 1-8)(Tigan, Jeremy) (Entered: 03/17/2023) (0) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Main Document) (5) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 1) (26) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 2) (26) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibits 3-6) (1) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 7) (5) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibits 8-12) (1) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 13) (13) |
| Mar 16, 2023 | 91 | REDACTED VERSION of 87 Letter,, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibits 3-6, # 4 Exhibit 7, # 5 Exhibits 8-12, # 6 Exhibit 13, # 7 Exhibit 14)(Phillips, John) (Entered: 03/16/2023) (Exhibit 14) (4) |
| Mar 15, 2023 | 90 | STIPULATION TO EXTEND TIME for Plaintiffs Galderma Laboratories, L.P. and TCD Royalty Sub LP to respond to Defendants Lupin Inc. and Lupin Limited's Motion for Leave to Amend Answer and Counterclaims (D.I. 86) to March 17, 2023 - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 03/15/2023) (1) |
| Mar 14, 2023 | 89 | NOTICE of Subpoenas to Amneal Pharmaceuticals LLC and Sun Pharmaceutical Industries Limited by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Haney, Megan) (Entered: 03/14/2023) (Main Document) (1) |
| Mar 14, 2023 | 89 | NOTICE of Subpoenas to Amneal Pharmaceuticals LLC and Sun Pharmaceutical Industries Limited by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Haney, Megan) (Entered: 03/14/2023) (Exhibit 1) (27) |
| Mar 14, 2023 | 89 | NOTICE of Subpoenas to Amneal Pharmaceuticals LLC and Sun Pharmaceutical Industries Limited by Lupin Inc., Lupin Limited (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Haney, Megan) (Entered: 03/14/2023) (Exhibit 2) (27) |
| Mar 10, 2023 | 88 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Third Set of Interrogatories (Nos. 11-16) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/10/2023) (3) |
| Mar 9, 2023 | 86 | MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims - filed by Lupin Inc., Lupin Limited. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 03/09/2023) (Main Document) (1) |
| Mar 9, 2023 | 87 | [SEALED] Letter to the Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Opening Letter Brief in Support of Motion for Leave to Amend - re 86 MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Phillips, John) (Main Document 87 replaced on 3/21/2023) (mkr). (Entered: 03/09/2023) (0) |
| Mar 9, 2023 | 86 | MOTION to Amend/Correct Motion for Leave to Amend Answer and Counterclaims - filed by Lupin Inc., Lupin Limited. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 03/09/2023) (Text of Proposed Order) (1) |
| Mar 7, 2023 | 85 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Fifth Set of Interrogatories to Plaintiffs (Nos. 22-25) and Lupin Inc. and Lupin Limited's Fifth Set of Requests for Production (Nos. 20-33) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 03/07/2023) (2) |
| Mar 3, 2023 | 84 | NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Interrogatories to Lupin Inc. and Lupin Limited (Nos. 8-11); (2) Plaintiffs' First Supplemental Objections and Responses to Defendants' Third Set of Requests for Production (Nos. 14-17); and (3) Plaintiffs' Second Supplemental Infringement Claim Chart filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 03/03/2023) (3) |
| Feb 28, 2023 | 80 | NOTICE to Take Deposition of Arash Raoufinia Pursuant to Rule 30(b)(1) on March 24, 2023 filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 02/28/2023) (2) |
| Feb 28, 2023 | 81 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Notice of Deposition of Plaintiffs Pursuant to Fed. R. Civ. P. 30(b)(6) and Lupin Inc. and Lupin Limited's Fourth Set of Interrogatories to Plaintiffs (Nos. 17-21) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 02/28/2023) (2) |
| Feb 28, 2023 | 82 | NOTICE to Take Deposition of Rajiv Khurana on March 16, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 02/28/2023) (3) |
| Feb 28, 2023 | 83 | NOTICE to Take Deposition of Sanjay Wagh on March 16, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 02/28/2023) (3) |
| Feb 23, 2023 | 78 | NOTICE to Take Deposition of Makarand Avachat on March 29, 2023 filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 02/23/2023) (3) |
| Feb 23, 2023 | 79 | REDACTED VERSION of 74 Letter by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit A)(Phillips, John) (Entered: 02/23/2023) (Main Document) (1) |
| Feb 23, 2023 | 79 | REDACTED VERSION of 74 Letter by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit A)(Phillips, John) (Entered: 02/23/2023) (Exhibit A) (3) |
| Feb 21, 2023 | 77 | REDACTED VERSION of 73 Letter, to The Honorable Stephanos Bibas from Jeremy A. Tigan by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 12-21)(Tigan, Jeremy) (Entered: 02/21/2023) (Main Document) (4) |
| Feb 21, 2023 | 77 | REDACTED VERSION of 73 Letter, to The Honorable Stephanos Bibas from Jeremy A. Tigan by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 12-21)(Tigan, Jeremy) (Entered: 02/21/2023) (Exhibits 12-21) (30) |
| Feb 17, 2023 | 75 | Letter to The Honorable Stephanos Bibas from Jack B. Blumenfeld regarding motion for summary judgment - re 74 Letter. (Blumenfeld, Jack) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 76 | ORAL ORDER, I DENY Lupin's request for leave to file a motion for summary judgment (D.I. 64 ). Ordered by Judge Stephanos Bibas on 2/17/2023. (twk) (Entered: 02/17/2023) (0) |
| Feb 16, 2023 | 74 | [SEALED] Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Lupin's request for leave to file a reply in support of its motion for leave for summary judgment. (Attachments: # 1 Exhibit A)(Phillips, John) (Entered: 02/16/2023) (0) |
| Feb 13, 2023 | 73 | [SEALED] Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Plaintiffs' Response to Lupin's Request for Leave to File a Summary Judgment Motion - re 64 Letter,. (Attachments: # 1 Exhibits 12-21)(Tigan, Jeremy) (Entered: 02/13/2023) (0) |
| Feb 10, 2023 | 72 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs' Fourth Set of Requests for Production (Nos. 132-134) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 02/10/2023) (2) |
| Feb 8, 2023 | 70 | NOTICE of Change of Firm Affiliation by Galderma Laboratories L.P., TCD Royalty Sub LP (Tigan, Jeremy) (Entered: 02/08/2023) (2) |
| Feb 8, 2023 | 71 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Third Set of Interrogatories to Plaintiffs (Nos. 11-16) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 02/08/2023) (2) |
| Feb 3, 2023 | 67 | NOTICE requesting Clerk to remove Evan D. Diamond, Vanessa Y. Yen, and the law firm of King & Spalding LLP as co-counsel.. (Tigan, Jeremy) (Entered: 02/03/2023) (2) |
| Feb 3, 2023 | 68 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Second Set of Interrogatories (Nos. 6-10); (2) Plaintiffs' Objections and Responses to Defendants' Second Set of Requests for Admission (Nos. 20-23); and (3) Plaintiffs' First Supplemental Infringement Claim Chart filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 02/03/2023) (3) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Main Document) (4) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 1) (1) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 2) (11) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 3) (8) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 4-7) (1) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 8) (2) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 9) (9) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 10) (21) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Exhibit 11) (16) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (Proposed Order) (1) |
| Feb 3, 2023 | 69 | REDACTED VERSION of 64 Letter, by Lupin Inc., Lupin Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4-7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10, # 8 Exhibit 11, # 9 Proposed Order, # 10 7.1.1 Statement)(Phillips, John) (Entered: 02/03/2023) (7.1.1 Statement) (1) |
| Jan 30, 2023 | 65 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Fourth Set of Requests for Production (Nos. 18-19) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 01/30/2023) (3) |
| Jan 30, 2023 | 66 | ORAL ORDER, Plaintiffs shall respond in writing to Defendants' request to file a motion for summary judgment (D.I. 64 ) no later than February 13, 2023 (Notice of Compliance deadline set for 2/13/2023.) Signed by Judge Stephanos Bibas on 1/30/2023. (apk) (Entered: 01/30/2023) (0) |
| Jan 27, 2023 | 64 | [SEALED] Letter to the Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Lupin's Request for Leave to File a Summary Judgment Motion. (Attachments: # 1 Exhibit 1 (Part 1/2), # 2 Exhibit 1 (Part 2/2), # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Text of Proposed Order, # 14 D. Del. LR 7.1.1 Statement)(Phillips, John) (Entered: 01/27/2023) (0) |
| Jan 18, 2023 | 63 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Third Set of Requests for Production (Nos. 14-17) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 01/18/2023) (3) |
| Jan 13, 2023 | 62 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 01/13/2023) (2) |
| Jan 11, 2023 | 61 | NOTICE OF SERVICE of Plaintiffs' Fourth Set of Requests for the Production of Documents and Things (Nos. 132-134) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 01/11/2023) (3) |
| Jan 5, 2023 | 60 | NOTICE of Change of Firm Affiliation by Galderma Laboratories L.P., TCD Royalty Sub LP (Blumenfeld, Jack) (Entered: 01/05/2023) (3) |
| Jan 4, 2023 | 59 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Second Set of Interrogatories to Plaintiffs (Nos. 6-10) and Lupin Inc. and Lupin Limited's Second Set of Requests for Admission (Nos. 20-23) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 01/04/2023) (2) |
| Dec 30, 2022 | 58 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs Third Set of Requests for Production (No. 131) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 12/30/2022) (2) |
| Dec 29, 2022 | 57 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Fourth Set of Requests for Production (Nos. 18-19) and Defendants Lupin Inc. and Lupin Limited's Supplemental Responses and Objections to Plaintiffs First Set of Requests for Production (Nos. 1-2) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 12/29/2022) (2) |
| Dec 23, 2022 | 56 | Interim STATUS REPORT by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 12/23/2022) (3) |
| Dec 20, 2022 | 55 | NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Third Set of Requests for Production (Nos. 14-17) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 12/20/2022) (2) |
| Dec 19, 2022 | 54 | NOTICE OF SERVICE of Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs Second Set of Requests for Production (Nos. 119-130) and Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-7) filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 12/19/2022) (2) |
| Dec 1, 2022 | 53 | SO ORDERED, regarding D.I. 51 STIPULATION TO EXTEND TIME for the parties to file any motions to join other parties, and to amend or supplement the pleadings pursuant to paragraph 3 of the Scheduling Order (D.I. 18 ) to December 7, 2022 filed by Lupin Inc., Lupin Limited. Signed by Judge Stephanos Bibas on 12/1/2022. (apk) (Entered: 12/01/2022) (0) |
| Nov 30, 2022 | 51 | STIPULATION TO EXTEND TIME for the parties to file any motions to join other parties, and to amend or supplement the pleadings pursuant to paragraph 3 of the Scheduling Order (D.I. 18) to December 7, 2022 - filed by Lupin Inc., Lupin Limited. (Haney, Megan) (Entered: 11/30/2022) (2) |
| Nov 30, 2022 | 52 | NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (No. 131) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 11/30/2022) (3) |
| Nov 28, 2022 | 48 | REDACTED VERSION of 45 Joint Claim Construction Brief by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exs. A-G)(Tigan, Jeremy) (Entered: 11/28/2022) (Main Document) (30) |
| Nov 28, 2022 | 49 | [SEALED] STATEMENT -- Plaintiffs Galderma Laboratories, L.P. and TCD Royalty Sub LP's Comments on Defendants Lupin Inc. and Lupin Limited's Claim Construction Technology Tutorial -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 11/28/2022) (0) |
| Nov 28, 2022 | 50 | STATEMENT Lupin's Comments on Plaintiffs' Technology Tutorial by Lupin Inc., Lupin Limited. (Haney, Megan) (Entered: 11/28/2022) (4) |
| Nov 28, 2022 | 48 | REDACTED VERSION of 45 Joint Claim Construction Brief by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exs. A-G)(Tigan, Jeremy) (Entered: 11/28/2022) (Exs. A-G) (30) |
| Nov 21, 2022 | 45 | [SEALED] JOINT CLAIM CONSTRUCTION BRIEF filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits A-G)(Tigan, Jeremy) (Entered: 11/21/2022) (0) |
| Nov 21, 2022 | 46 | STATEMENT -- Plaintiffs' Technology Tutorial -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 11/21/2022) (20) |
| Nov 21, 2022 | 47 | STATEMENT -- Lupin's Technology Tutorial -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 11/21/2022) (19) |
| Nov 18, 2022 | 44 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Lupin Inc. and Lupin Limited (Nos. 1-7); (2) Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 119-130); and (3) Plaintiffs' Notice of Deposition of Lupin Pursuant to Fed. R. Civ P. 30(b)(6) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 11/18/2022) (3) |
| Nov 16, 2022 | 43 | NOTICE OF SERVICE of Joint Claim Construction Brief Containing Lupin's Sur-Reply Brief filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 11/16/2022) (2) |
| Nov 14, 2022 | 42 | NOTICE OF SERVICE of Lupin's Technology Tutorial filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 11/14/2022) (2) |
| Nov 4, 2022 | 41 | NOTICE OF SERVICE of Plaintiffs' Technology Tutorial filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 11/04/2022) (3) |
| Oct 28, 2022 | 40 | NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 10/28/2022) (3) |
| Oct 14, 2022 | 38 | Joint Letter to The Honorable Stephanos Bibas from Jeremy A. Tigan regarding Claim Construction Hearing. (Tigan, Jeremy) (Entered: 10/14/2022) (1) |
| Oct 14, 2022 | 39 | NOTICE OF SERVICE of Lupin's Answering Claim Construction Brief filed by Lupin Inc., Lupin Limited.(Haney, Megan) (Entered: 10/14/2022) (2) |
| Sep 29, 2022 | 37 | ORAL ORDER, Plaintiffs have asked me to change tutorial deadlines D.I. 36 . Defendants have not weighed in. I therefore modify the scheduling order as follows: The parties joint or separate claim construction technology tutorials are due on November 21, 2022. Each party may comment in writing (in no more than five pages) on the opposing partys tutorial no later than November 28, 2022. Signed by Judge Stephanos Bibas on 9/29/2022. (apk) (Entered: 09/29/2022) (0) |
| Sep 23, 2022 | 35 | NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 09/23/2022) (3) |
| Sep 23, 2022 | 36 | MOTION to Modify the Scheduling Order re 18 Scheduling Order,, Set Deadlines/Hearings, - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) (Entered: 09/23/2022) (3) |
| Sep 2, 2022 | 33 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Requests for Production (Nos. 8-13) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 09/02/2022) (3) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Main Document) (13) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibits 1-14) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibits 15-21) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 22) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 1 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 2 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 3 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 4 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 5 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 6 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibit 23 (Part 7 of 7)) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibits 24-25) (30) |
| Sep 2, 2022 | 34 | CLAIM Construction Chart by Galderma Laboratories L.P., TCD Royalty Sub LP. (Attachments: # 1 Exhibits 1-14, # 2 Exhibits 15-21, # 3 Exhibit 22, # 4 Exhibit 23 (Part 1 of 7), # 5 Exhibit 23 (Part 2 of 7), # 6 Exhibit 23 (Part 3 of 7), # 7 Exhibit 23 (Part 4 of 7), # 8 Exhibit 23 (Part 5 of 7), # 9 Exhibit 23 (Part 6 of 7), # 10 Exhibit 23 (Part 7 of 7), # 11 Exhibits 24-25, # 12 Exhibits 26-27)(Tigan, Jeremy) (Entered: 09/02/2022) (Exhibits 26-27) (30) |
| Aug 29, 2022 | 32 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-5) and (2) Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-19) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 08/29/2022) (3) |
| Aug 22, 2022 | 31 | NOTICE OF SERVICE of Plaintiffs' Identification of Claim Terms and Phrases for Construction and Proposed Constructions filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) (Entered: 08/22/2022) (3) |
| Aug 3, 2022 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's Second Set of Requests for Production (Nos. 8-13) filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| Jul 29, 2022 | 28 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Request for Production of Documents and Things (Nos. 1-7) filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Jul 29, 2022 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's First Set of Interrogatories to Plaintiffs (Nos. 1-5); Lupin Inc. and Lupin Limited's First Set of Requests for Admission (Nos. 1-19) and Defendants Lupin Inc. and Lupin Limited's Responses and Objections to Plaintiffs First Set of Requests for Production (Nos. 1-118) filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| Jul 22, 2022 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Chart filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Jun 29, 2022 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| Jun 29, 2022 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Inc. and Lupin Limited's First Set of Requests for Production filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| May 24, 2022 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Parties' Proposed ESI Order filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| May 24, 2022 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's Initial Disclosures Pursuant to Paragraph 3 of the Stipulated Order Regarding Discovery filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| May 23, 2022 | 22 | Stipulation and Order (11) Docket Text: STIPULATED ORDER re [19] [Proposed] Stipulated Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI"). Signed by Judge Stephanos Bibas on 5/23/2022. (nmg) |
| May 20, 2022 | 19 | Proposed Order (11) Docket Text: PROPOSED ORDER -- [Proposed] Stipulated Order Regarding Discovery, Including Discovery of Electronically Stored Information ("ESI") by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| May 20, 2022 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Inc., Lupin Limited.(Haney, Megan) |
| May 20, 2022 | 21 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Galderma Laboratories L.P., TCD Royalty Sub LP.(Tigan, Jeremy) |
| May 19, 2022 | 18 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Joinder of Parties and Amendment of Pleadings due by 11/30/2022. Fact Discovery completed by 4/7/2023. Opening Expert Reports due by 6/2/2023. Rebuttal Expert Reports due by 8/11/2023. Joint Claim Construction Brief due by 11/21/2022. (See Order for further Deadlines and Hearings). Signed by Judge Stephanos Bibas on 5/19/2022. (twk) |
| May 18, 2022 | 17 | Main Document (1) Docket Text: Letter to The Honorable Stephanos Bibas from Megan C. Haney regarding Chart with Competing Date Proposals for Rule 16 Hearing. (Attachments: # (1) Exhibit A)(Haney, Megan) |
| May 18, 2022 | 17 | Exhibit A (3) |
| May 11, 2022 | 16 | Main Document (1) Docket Text: Letter to The Honorable Stephanos Bibas from John C. Phillips, Jr. regarding Request for Scheduling Conference. (Attachments: # (1) Proposed Scheduling Order)(Phillips, John) |
| May 11, 2022 | 16 | Proposed Scheduling Order (13) |
| Apr 28, 2022 | 15 | Protective Order (19) Docket Text: PROTECTIVE ORDER. Signed by Judge Stephanos Bibas on 4/28/2022. (cna, ) |
| Apr 27, 2022 | 14 | Proposed Order (19) Docket Text: PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Galderma Laboratories L.P., TCD Royalty Sub LP. (Tigan, Jeremy) |
| Mar 22, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Vanessa Y. Yen and Evan D. Diamond for Galderma Laboratories L.P., and TCD Royalty Sub LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 18, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Stephanos Bibas, of the United States Court of Appeals for the Third Circuit. Please include the initials of the Judge (SB) after the case number on all documents filed. (rjb) |
| Mar 18, 2022 | 13 | Order (1) Docket Text: ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Signed by Judge Michael A Chagares, Chief Judge of the United States Court of Appeals for the Third Circuit on 3/18/2022. (rjb) |
| Mar 1, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrew J. Cochran and Gerald J. Flattmann, Jr for Galderma Laboratories L.P. and TCD Royalty Sub LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Feb 28, 2022 | 12 | Answer to Counterclaim (9) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim -- Answer to Counterclaims -- by Galderma Laboratories L.P., TCD Royalty Sub LP.(Blumenfeld, Jack) |
| Feb 7, 2022 | 10 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, with Jury Demand Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Limited, Lupin Inc..(Phillips, John) |
| Feb 7, 2022 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Inc. filed by Lupin Inc., Lupin Limited. (Phillips, John) |
| Jan 24, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew J. Cochran filed by Galderma Laboratories L.P., TCD Royalty Sub LP. Signed by Judge Leonard P. Stark on 1/24/22. (ntl) |
| Jan 24, 2022 | 9 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr., Evan D. Diamond, Vanessa Y. Yen and Andrew J. Cochran - filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (Blumenfeld, Jack) |
| Jan 12, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Joseph T. Jaros, Natasha L. White, Adrianne C. Rose, and William A. Rakoczy for Lupin Inc. and Lupin Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Jan 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros, Natasha L. White and Adrianne C. Rose filed by Lupin Inc., Lupin Limited. Signed by Judge Leonard P. Stark on 1/11/22. (ntl) |
| Jan 11, 2022 | 8 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros, Natasha L. White and Adrianne C. Rose - filed by Lupin Inc., Lupin Limited. (Attachments: # (1) Certification of William A. Rakoczy, # (2) Certification of Joseph T. Jaros, # (3) Certification of Natasha L. White, # (4) Certification of Adrianne C. Rose)(Haney, Megan) |
| Jan 11, 2022 | 8 | Certification of William A. Rakoczy (1) |
| Jan 11, 2022 | 8 | Certification of Joseph T. Jaros (1) |
| Jan 11, 2022 | 8 | Certification of Natasha L. White (1) |
| Jan 11, 2022 | 8 | Certification of Adrianne C. Rose (1) |
| Dec 9, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by TCD Royalty Sub LP, Galderma Laboratories L.P.: For Lupin Inc. waiver sent on 12/7/2021, answer due 2/7/2022; Lupin Limited waiver sent on 12/7/2021, answer due 2/7/2022. (Blumenfeld, Jack) |
| Dec 8, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Dec 3, 2021 | 1 | Main Document (10) Docket Text: COMPLAINT filed against Lupin Inc., Lupin Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3755546.) - filed by TCD Royalty Sub LP, Galderma Laboratories L.P.. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(apk) |
| Dec 3, 2021 | 1 | Exhibit A-F (119) |
| Dec 3, 2021 | 1 | Civil Cover Sheet (1) |
| Dec 3, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Dec 3, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/22/2021. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 4/22/2024. (apk) |
| Dec 3, 2021 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2 ;8,206,740 B2 ;8,394,405 B2 ;8,394,406 B2 ;8,470,364 B2 ;8,709,478 B2. (apk) |
| Dec 3, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Drug Royalty III LP 2, Corporate Parent DRI Healthcare Trust for TCD Royalty Sub LP; Corporate Parent Galderma Services Inc. for Galderma Laboratories L.P. filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (apk) |
| Dec 3, 2021 | 6 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Inc. on 12/3/2021; Lupin Limited on 12/3/2021. (Attachments: # (1) Summons Issued)(apk) |
| Dec 3, 2021 | 6 | Summons Issued (2) |
| Dec 3, 2021 | 1 | Complaint* (1) |
